nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—CYP1A2—urine—polycystic ovary syndrome	0.063	0.147	CbGeAlD
Carmustine—GSR—embryo—polycystic ovary syndrome	0.0599	0.14	CbGeAlD
Carmustine—GSR—Sulfation Biotransformation Reaction—SULT2A1—polycystic ovary syndrome	0.0537	0.119	CbGpPWpGaD
Carmustine—GSR—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—polycystic ovary syndrome	0.0497	0.11	CbGpPWpGaD
Carmustine—GSR—endometrium—polycystic ovary syndrome	0.0438	0.102	CbGeAlD
Carmustine—GSR—uterus—polycystic ovary syndrome	0.0404	0.0942	CbGeAlD
Carmustine—GSR—pituitary gland—polycystic ovary syndrome	0.0397	0.0925	CbGeAlD
Carmustine—GSR—adipose tissue—polycystic ovary syndrome	0.0395	0.0921	CbGeAlD
Carmustine—GSR—adrenal gland—polycystic ovary syndrome	0.0354	0.0826	CbGeAlD
Carmustine—GSR—female gonad—polycystic ovary syndrome	0.033	0.0771	CbGeAlD
Carmustine—GSR—vagina—polycystic ovary syndrome	0.0328	0.0766	CbGeAlD
Carmustine—GSR—endocrine gland—polycystic ovary syndrome	0.0307	0.0717	CbGeAlD
Carmustine—GSR—Oxidative Stress—CYP1A1—polycystic ovary syndrome	0.0179	0.0397	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.0163	0.036	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.0154	0.0341	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.0127	0.0281	CbGpPWpGaD
Carmustine—Azotaemia—Metformin—polycystic ovary syndrome	0.0122	0.102	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.0109	0.0242	CbGpPWpGaD
Carmustine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.0104	0.0244	CbGeAlD
Carmustine—GSR—Cellular responses to stress—HMGA2—polycystic ovary syndrome	0.00954	0.0211	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00904	0.02	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00832	0.0184	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CCNE2—polycystic ovary syndrome	0.0079	0.0175	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00737	0.0163	CbGpPWpGaD
Carmustine—Accidental injury—Metformin—polycystic ovary syndrome	0.00734	0.0613	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00706	0.0156	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00696	0.0154	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00685	0.0152	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00672	0.0149	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00667	0.0148	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.00635	0.0141	CbGpPWpGaD
Carmustine—Neuropathy—Metformin—polycystic ovary syndrome	0.0061	0.0509	CcSEcCtD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.00578	0.0128	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00562	0.0124	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00558	0.0124	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00542	0.012	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—NRG1—polycystic ovary syndrome	0.00523	0.0116	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00516	0.0114	CbGpPWpGaD
Carmustine—Injury—Metformin—polycystic ovary syndrome	0.00513	0.0428	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CAMK2D—polycystic ovary syndrome	0.00501	0.0111	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TNRC6B—polycystic ovary syndrome	0.00493	0.0109	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00437	0.00968	CbGpPWpGaD
Carmustine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00435	0.0364	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00431	0.00954	CbGpPWpGaD
Carmustine—GSR—Metabolism—NMNAT3—polycystic ovary syndrome	0.0039	0.00864	CbGpPWpGaD
Carmustine—Neutropenia—Metformin—polycystic ovary syndrome	0.00381	0.0318	CcSEcCtD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00365	0.00808	CbGpPWpGaD
Carmustine—GSR—Metabolism—LPCAT2—polycystic ovary syndrome	0.00357	0.0079	CbGpPWpGaD
Carmustine—GSR—Metabolism—SUOX—polycystic ovary syndrome	0.00357	0.0079	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00356	0.0297	CcSEcCtD
Carmustine—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00332	0.00735	CbGpPWpGaD
Carmustine—GSR—Metabolism—ISYNA1—polycystic ovary syndrome	0.00331	0.00734	CbGpPWpGaD
Carmustine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00325	0.0271	CcSEcCtD
Carmustine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00321	0.0268	CcSEcCtD
Carmustine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00321	0.0268	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.00306	0.00678	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00305	0.00676	CbGpPWpGaD
Carmustine—Eye disorder—Metformin—polycystic ovary syndrome	0.00305	0.0255	CcSEcCtD
Carmustine—Flushing—Metformin—polycystic ovary syndrome	0.00303	0.0253	CcSEcCtD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00293	0.0065	CbGpPWpGaD
Carmustine—Malnutrition—Metformin—polycystic ovary syndrome	0.00284	0.0237	CcSEcCtD
Carmustine—Erythema—Metformin—polycystic ovary syndrome	0.00284	0.0237	CcSEcCtD
Carmustine—GSR—Metabolism—TEAD2—polycystic ovary syndrome	0.00282	0.00624	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKR1C2—polycystic ovary syndrome	0.00282	0.00624	CbGpPWpGaD
Carmustine—Vision blurred—Metformin—polycystic ovary syndrome	0.00268	0.0223	CcSEcCtD
Carmustine—Tremor—Metformin—polycystic ovary syndrome	0.00266	0.0222	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00245	0.00544	CbGpPWpGaD
Carmustine—Hypertension—Metformin—polycystic ovary syndrome	0.00245	0.0205	CcSEcCtD
Carmustine—Myalgia—Metformin—polycystic ovary syndrome	0.00242	0.0202	CcSEcCtD
Carmustine—Chest pain—Metformin—polycystic ovary syndrome	0.00242	0.0202	CcSEcCtD
Carmustine—GSR—Metabolism—PNPLA2—polycystic ovary syndrome	0.00236	0.00523	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00233	0.00517	CbGpPWpGaD
Carmustine—Oedema—Metformin—polycystic ovary syndrome	0.00232	0.0194	CcSEcCtD
Carmustine—Infection—Metformin—polycystic ovary syndrome	0.0023	0.0192	CcSEcCtD
Carmustine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00227	0.0189	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00227	0.00502	CbGpPWpGaD
Carmustine—GSR—Metabolism—SRD5A1—polycystic ovary syndrome	0.00224	0.00496	CbGpPWpGaD
Carmustine—Anorexia—Metformin—polycystic ovary syndrome	0.00221	0.0184	CcSEcCtD
Carmustine—Hypotension—Metformin—polycystic ovary syndrome	0.00217	0.0181	CcSEcCtD
Carmustine—GSR—Metabolism—STAR—polycystic ovary syndrome	0.00214	0.00473	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00214	0.00473	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00211	0.0176	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00211	0.00467	CbGpPWpGaD
Carmustine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00208	0.0174	CcSEcCtD
Carmustine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00207	0.0173	CcSEcCtD
Carmustine—Somnolence—Metformin—polycystic ovary syndrome	0.00206	0.0172	CcSEcCtD
Carmustine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00202	0.0168	CcSEcCtD
Carmustine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.002	0.0167	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.002	0.00443	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00199	0.0044	CbGpPWpGaD
Carmustine—Constipation—Metformin—polycystic ovary syndrome	0.00198	0.0166	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00196	0.00434	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00194	0.00431	CbGpPWpGaD
Carmustine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00191	0.0159	CcSEcCtD
Carmustine—GSR—Metabolism—HMMR—polycystic ovary syndrome	0.0019	0.00422	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0019	0.0158	CcSEcCtD
Carmustine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00183	0.0153	CcSEcCtD
Carmustine—GSR—Metabolism—HSD3B1—polycystic ovary syndrome	0.00182	0.00402	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00177	0.00393	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00173	0.00384	CbGpPWpGaD
Carmustine—Asthenia—Metformin—polycystic ovary syndrome	0.00166	0.0139	CcSEcCtD
Carmustine—GSR—Metabolism—LHB—polycystic ovary syndrome	0.00166	0.00367	CbGpPWpGaD
Carmustine—GSR—Metabolism—HSD3B2—polycystic ovary syndrome	0.00162	0.00359	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00161	0.00357	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00161	0.00357	CbGpPWpGaD
Carmustine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00159	0.0132	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00157	0.00348	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKR1C1—polycystic ovary syndrome	0.00157	0.00347	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00157	0.00347	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00157	0.00347	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00157	0.00347	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00155	0.00344	CbGpPWpGaD
Carmustine—Dizziness—Metformin—polycystic ovary syndrome	0.00153	0.0128	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00151	0.00334	CbGpPWpGaD
Carmustine—Vomiting—Metformin—polycystic ovary syndrome	0.00147	0.0123	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.00147	0.00326	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00147	0.00325	CbGpPWpGaD
Carmustine—Rash—Metformin—polycystic ovary syndrome	0.00146	0.0122	CcSEcCtD
Carmustine—Dermatitis—Metformin—polycystic ovary syndrome	0.00146	0.0122	CcSEcCtD
Carmustine—Headache—Metformin—polycystic ovary syndrome	0.00145	0.0121	CcSEcCtD
Carmustine—GSR—Metabolism—SULT2A1—polycystic ovary syndrome	0.00144	0.0032	CbGpPWpGaD
Carmustine—GSR—Metabolism—RRM2—polycystic ovary syndrome	0.0014	0.0031	CbGpPWpGaD
Carmustine—Nausea—Metformin—polycystic ovary syndrome	0.00138	0.0115	CcSEcCtD
Carmustine—GSR—Metabolism—YAP1—polycystic ovary syndrome	0.00135	0.00298	CbGpPWpGaD
Carmustine—GSR—Metabolism—NAMPT—polycystic ovary syndrome	0.00129	0.00287	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP11A1—polycystic ovary syndrome	0.00128	0.00283	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00127	0.00282	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00127	0.00281	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00125	0.00277	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKR1C3—polycystic ovary syndrome	0.00121	0.00267	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP17A1—polycystic ovary syndrome	0.00119	0.00263	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00111	0.00247	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00104	0.0023	CbGpPWpGaD
Carmustine—GSR—Metabolism—TH—polycystic ovary syndrome	0.00103	0.00228	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00103	0.00228	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00102	0.00227	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—polycystic ovary syndrome	0.00102	0.00226	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC2A4—polycystic ovary syndrome	0.001	0.00222	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000985	0.00218	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000944	0.00209	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP19A1—polycystic ovary syndrome	0.00094	0.00208	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00092	0.00204	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000907	0.00201	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000857	0.0019	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000855	0.00189	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000843	0.00187	CbGpPWpGaD
Carmustine—GSR—Metabolism—GNAS—polycystic ovary syndrome	0.000839	0.00186	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOR1—polycystic ovary syndrome	0.000799	0.00177	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000779	0.00173	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000779	0.00173	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000766	0.0017	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP1A1—polycystic ovary syndrome	0.000758	0.00168	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000734	0.00163	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTHFR—polycystic ovary syndrome	0.000707	0.00157	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000677	0.0015	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000667	0.00148	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000653	0.00145	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000619	0.00137	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00059	0.00131	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—polycystic ovary syndrome	0.000573	0.00127	CbGpPWpGaD
Carmustine—GSR—Metabolism—POMC—polycystic ovary syndrome	0.000565	0.00125	CbGpPWpGaD
Carmustine—GSR—Metabolism—INS—polycystic ovary syndrome	0.000562	0.00125	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000545	0.00121	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000538	0.00119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000502	0.00111	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00048	0.00106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000458	0.00101	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000447	0.000991	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000439	0.000972	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000439	0.000972	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000433	0.00096	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000408	0.000904	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000407	0.000901	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000399	0.000883	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000372	0.000825	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000353	0.000783	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000347	0.000769	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000347	0.000769	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000334	0.000739	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000328	0.000727	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000291	0.000644	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000276	0.000611	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000263	0.000582	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00026	0.000576	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000234	0.000519	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000224	0.000495	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000221	0.00049	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000209	0.000464	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000204	0.000452	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000199	0.000441	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000193	0.000427	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000178	0.000393	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000172	0.000381	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000166	0.000367	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.000353	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000158	0.000351	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.000348	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000156	0.000346	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000149	0.000329	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.000324	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	0.000127	0.00028	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.000273	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.000256	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000229	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	9.84e-05	0.000218	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	9.33e-05	0.000207	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	8.7e-05	0.000193	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	7.05e-05	0.000156	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	6.95e-05	0.000154	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	6.92e-05	0.000153	CbGpPWpGaD
